
AbCellera
AI-powered platform for antibody discovery and development to create new medicines.
About
AbCellera is a technology company that partners with drug developers to discover and develop antibody therapeutics. Their AI-powered drug discovery platform integrates high-throughput screening, genomics, and AI to accelerate the identification of therapeutic antibodies from natural immune responses.
Listed competitors
Show 6 more similar companies
Also in this space
PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
Shares Biotech, Drug Discovery
Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
Shares Biotech, Drug Discovery
Narya Bio is developing novel therapeutic antibodies for challenging diseases.
Shares Biotech, Drug Discovery
Alvox Bio is a life sciences startup developing novel therapeutic antibodies.
Shares Biotech, Drug Discovery
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, HealthTech
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to AbCellera?
People comparing tools land here. Get listed beside these.
Copy AbCellera's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- abcellera.com
- Headquarters
- Vancouver, Canada
- Founded
- 2012
- Total funding
- $10M (Public Offering)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Aug 2026 | Public Offering | Undisclosed | |
| 24 May 2018 | Series A | $10M | DCVC |
Tech stack
Detected on abcellera.com, last scanned 6 Nov 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Status page
- Statuspage
Benchmarking
See how your site ranks against 16,849 startups
AbCellera sits in the 65th percentile for Domain Rating. Check where yours lands, free.
AbCellera has a Domain Rating of 56, the 65th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Above median
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Below median
PageSpeedData Trust
Top 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
AbCellera scores 38. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when AbCellera changes
Used AbCellera? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns AbCellera?
AbCellera is privately held, owned by its founders and investors. Investors on record include DCVC. Exact stakes are not public.
Are there companies like AbCellera?
Yes. We list 9 companies like AbCellera, including Exscientia, Recursion Pharmaceuticals and BenevolentAI.
Is AbCellera trustworthy and reputable?
StartupHub's Data Trust & Reputation score for AbCellera is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has AbCellera raised?
AbCellera has raised a total of $10M in funding. The most recent round on record is Public Offering.
SEC filings, insider activity, nonprofit links and pay benchmarks for AbCellera:
Company details: from public sources. Funding: 2 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch AbCellera and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


